Hadassah

Drug Developed by Hadassah Doctor Helps Severely Ill COVID-19 Patients

Thursday, Oct 1 2020

Photo Credit: Hadassah Medical Organization

All five of the seriously ill COVID-19 patients at Hadassah Hospital Ein Kerem who received an experimental treatment developed by a Hadassah physician have recovered, and they have tested negative for the coronavirus.

The five individuals, participating in the first clinical trial in the world to treat COVID-19 patients with human cells taken from healthy live donors, were discharged, on average, five or six days after receiving Allocetra™. The drug, based on the research of Prof. Dror Mevorach, head of Hadassah’s Internal Medicine B Department and one of Hadassah's COVID-19 outbreak units, was developed in collaboration with Enlivex, an Israeli biotechnology company.

Allocetra™ was originally created to treat a wide range of patients who have overactive immune systems, resulting in increased secretion of proteins called cytokines, which cause a “cytokine storm.” It has already been given successfully to 10 patients with sepsis. As explained on the company’s website, “Allocetra™ is an innovative immunotherapy that is being developed to rebalance life-threatening hyperactivity of the immune system, using the immune system’s own natural regulation mechanisms. By intelligently engaging macrophages and dendritic cells, Allocetra™ is designed to avert cytokine storms and restores safe immune balance without suppressing the immune system.”

The clinical trial in COVID-19 patients is being led by Prof. Vernon van Herdeen, head of Hadassah’s General Intensive Care Unit. See the February 6, 2020, issue of The Jerusalem Post for further background on Allocetra™.

Learn more about the Hadassah Medical Organization.

Related Stories

alt_text

Monday, Oct 19 2020

Hadassah Allows Family to Visit COVID-19 Patients to Enhance Recovery

Following the success of its unique visitor’s program, in which recovered COVID-19 volunteers have been visiting patients in the coronavirus outbreak units to provide extra care...

READ MORE ›
alt_text

Wednesday, Oct 14 2020

Prof. Dana Wolf's Fight Against Viruses in Israel

The clock said midnight and Prof. Dana Wolf’s phone was ringing. She recognized the number. It belonged to the head of Israel’s Ministry of Health National Laboratory Division.

READ MORE ›
alt_text

Wednesday, Oct 14 2020

[Hadassah On Call Podcast] The Path Towards a Cancer Cure

There’s a new leader walking the halls at Hadassah’s hospitals -- and he’s passionate about curing cancer.

READ MORE ›
alt_text

Thursday, Oct 8 2020

Newsweek ranks Hadassah Hospital Heart Institute in list of top global cardiology hospitals

For nine decades, Newsweek has covered all aspects of healthcare – medical specialties, scientific breakthroughs, challenges, technology, patient care and, most importantly, the impact these have on the world today.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Israel Travel

israeltravel@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

More ›

Show More